These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 33784233)

  • 21. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Kew KM; Mavergames C; Walters JA
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
    Wilson R; Anzueto A; Miravitlles M; Arvis P; Haverstock D; Trajanovic M; Sethi S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():985-93. PubMed ID: 26082623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
    Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
    J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    JAMA; 2018 Oct; 320(15):1548-1559. PubMed ID: 30326124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronotropic index during 6-minute walk and acute respiratory events in COPDGene.
    Macdonald DM; Palzer EF; Abbasi A; Baldomero AK; Bhatt SP; Casaburi R; Connett JE; Dransfield MT; Gaeckle NT; Mkorombindo T; Rossiter HB; Stringer WW; Tiller NB; Wendt CH; Zhao D; Kunisaki KM
    Respir Med; 2022 Apr; 194():106775. PubMed ID: 35203009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
    Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial.
    Engel B; Schindler C; Leuppi JD; Rutishauser J
    Swiss Med Wkly; 2017; 147():w14439. PubMed ID: 28634972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT.
    Dransfield MT; McAllister DA; Anderson JA; Brook RD; Calverley PMA; Celli BR; Crim C; Gallot N; Martinez FJ; Scanlon PD; Yates J; Vestbo J; Newby DE;
    Ann Am Thorac Soc; 2018 May; 15(5):608-614. PubMed ID: 29406772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective study.
    Planquette B; Péron J; Dubuisson E; Roujansky A; Laurent V; Le Monnier A; Legriel S; Ferre A; Bruneel F; Chiles PG; Bedos JP
    Int J Chron Obstruct Pulmon Dis; 2015; 10():379-88. PubMed ID: 25733827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triple Therapy versus Dual or Monotherapy with Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis.
    Mammen MJ; Lloyd DR; Kumar S; Ahmed AS; Pai V; Kunadharaju R; Gupta S; Nici L; Aaron SD; Alexander PE
    Ann Am Thorac Soc; 2020 Oct; 17(10):1308-1318. PubMed ID: 32692253
    [No Abstract]   [Full Text] [Related]  

  • 34. Giving Voice to People - Experiences During Mild to Moderate Acute Exacerbations of COPD.
    Machado A; Almeida S; Burtin C; Marques A
    Chronic Obstr Pulm Dis; 2022 Jul; 9(3):336-348. PubMed ID: 35532921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.
    Ferguson GT; Tashkin DP; Skärby T; Jorup C; Sandin K; Greenwood M; Pemberton K; Trudo F
    Respir Med; 2017 Nov; 132():31-41. PubMed ID: 29229103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute exacerbation of COPD during pulmonary rehabilitation: outcomes and risk prediction.
    Herer B; Chinet T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1767-1774. PubMed ID: 29881266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Six-minute walking and pulmonary function test outcomes during the early period after lung cancer surgery with special reference to patients with chronic obstructive pulmonary disease.
    Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K
    Jpn J Thorac Cardiovasc Surg; 2004 Mar; 52(3):113-9. PubMed ID: 15077844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability in eosinophil categorisation during subsequent severe exacerbations of COPD.
    Citgez E; van der Palen J; van der Valk P; Kerstjens HAM; Brusse-Keizer M
    BMJ Open Respir Res; 2021 Aug; 8(1):. PubMed ID: 34376399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®).
    Vogelmeier CF; Asijee GM; Kupas K; Beeh KM
    Adv Ther; 2015 Jun; 32(6):537-47. PubMed ID: 26100349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
    Cheyne L; Irvin-Sellers MJ; White J
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009552. PubMed ID: 24043433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.